LANDSBERGER, NICOLETTA
LANDSBERGER, NICOLETTA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Spatially resolved mapping of histones reveals selective neuronal response in Rett syndrome
2026 F. Schäfer, G. De Rocco, M. Völker‐albert, I. Forne, N. Landsberger, A. Imhof, S. Lahiri
Illuminating the role of a T-Dark Gene in Rett Syndrome by studying the protein–protein interactions
2025 J. Sandakly, S. Pezzini, N. Landsberger
Overcoming premature termination codons in neurodevelopmental diseases with Anticodon Engineered tRNAs
2025 S. Pezzini, A. Mustaccia, E. Fara, P. Aboa, G. Faustini, A. Branchini, M. Pinotti, A. Frasca, J. J Porter, J. D Lueck, N. Landsberger
Role of IL-6 in Rett syndrome: from in vitro findings to in vivo therapeutic target validation
2025 O. Roggero, M. Breccia, F. Postogna, F. Biella, N. Landsberger, E. Boda, A. Frasca
The interplay between HPCAL4 and MeCP2: identification and characterization of a novel putative target for Rett syndrome therap
2025 J. Sandakly, S. Pezzini, L. Scandella, E. Fraviga, D. Pozzi, M. Francolini, N. Landsberger
Cholesterol dysregulation in Rett syndrome: implications for synaptic function
2025 F. Postogna, M. Breccia, O. Roggero, F. Biella, C. Cabasino, A. Arcari, N. Giancroce, N. Landsberger, A. Frasca
Anticodon-edited tRNAs: a novel strategy to suppress premature stop codons in Rett syndrome
2025 E. Fara, G. Arpaia, S. Pezzini, N. Landsberger
Cholesterol as a synaptogenic factor involved in the development of proper synaptic structure in an hiPSC-derived neurons model of Rett syndrome
2025 F. Biella, F.M. Postogna, N. Giancroce, O.M. Roggero, N. Landsberger, A. Frasca
Deciphering the role of the Tdark gene HPCAL4 in neurodevelopment and Rett syndrome
2025 S. Pezzini, J. Sandakly, L. Scandella, E. Fraviga, D. Pozzi, M. Francolini, N. Landsberger
Longitudinal analysis of age-dependent phenotypes in hemizygous male and heterozygous female Cdkl5 mutant mice
2025 A.L. Kannan, A. Patnaik, A. Theurer, L. Demuth, M. Korte, N. Landsberger, M. Zagrebelsky
Cholesterol dysregulation in Rett syndrome: implications for synaptic function
2025 F.M. Postogna, F. Biella, O.M. Roggero, N. Giancroce, N. Landsberger, M. Valenza, A. Frasca
Targeting early network dysfunction in Rett syndrome through AMPA-receptor modulation
2025 G. De Rocco, A. De Donato, V. Varotto, M. Indrigo, A. Frasca, N. Landsberger
Unveiling the effect of early glutamatergic stimulation for Rett syndrome treatment
2025 A. De Donato, G. De Rocco, M. Indrigo, V. Varotto, A. Cantamessa, F. Bedogni, N. Landsberger
Targeting neuronal circuits as a new frontier in Rett syndrome treatment
2025 A. De Donato, G. De Rocco, M. Indrigo, V. Varotto, A. Cantamessa, F. Bedogni, N. Landsberger
Rett syndrome: a complex disorder with promising therapeutic prospects
2025 J. Sandakly, A. Frasca, N. Landsberger
Neural Precursor Cells as a potential therapeutic approach for Rett Syndrome: identification of the involved molecular mechanisms
2024 M. BALBONTIN ARENAS, F.M. Postogna, E. Butti, A. Frasca, N. Landsberger
Role of interleukin 6 in the pathogenesis of Rett syndrome: focus on astrocyte-neuron crosstalk and its therapeutic implication
2024 O. Roggero, M. Breccia, F. Biella, F. Postogna, N. Landsberger, A. Frasca
Mecp2 knock-out astrocytes affect synaptogenesis by Interleukin 6 dependent mechanisms
2024 E. Albizzati, M. Breccia, E.M. Florio, C. Cabasino, F.M. Postogna, R. Grassi, E. Boda, C. Battaglia, C. De Palma, C. De Quattro, D. Pozzi, N. Landsberger, A. Frasca
Towards a new genetic player in the pathophysiology of Rett Syndrome
2024 J. Sandakly, S. Pezzini, L. Scandella, A. Arcari, E. Fraviga, D. Pozzi, M. Francolini, N. Landsberger
Engineered tRNAs efficiently suppress CDKL5 premature termination codons
2024 S. Pezzini, A. Mustaccia, P. Aboa, G. Faustini, A. Branchini, M. Pinotti, A. Frasca, J.J. Porter, J.D. Lueck, N. Landsberger